You just read:

MabVax Therapeutics Reports Positive Safety Results from Initial Cohort of MVT-1075 Radioimmunotherapy Phase 1 Trial for the Treatment of Pancreatic, Colon and Lung Cancers

News provided by

MabVax Therapeutics Holdings, Inc.

Feb 28, 2018, 07:30 ET